Antibody-drug Conjugates (ADC)

NH2-PEG6-CH2CH2COOH is a cleavable six-unit polyethylene glycol (PEG) linker specifically designed for antibody-drug conjugate (ADC) applications. This versatile compound facilitates the attachment of drugs to antibodies, enhancing therapeutic efficacy. Additionally, NH2-PEG6-CH2CH2COOH serves as a PEG-based linker for the development of PROTACs, supporting targeted protein degradation research. Its unique structure allows for improved solubility and bioavailability in various biological assays.

BCN-PEG4-NHS ester is a PEG-based linker specifically designed for the synthesis of PROTACs (Proteolysis Targeting Chimeras). Its primary mechanism involves the BCN group, which facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. This reagent is essential for enabling targeted protein degradation and enhancing the therapeutic potential of PROTACs in chemical biology research. Additionally, it serves as an effective tool for bioconjugation applications, expanding the versatility of synthetic approaches in drug discovery.

Alloc-Val-Ala-pAB is a peptide-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). The Val-Ala segment is selectively cleaved by the enzyme Cathepsin B, facilitating the targeted release of cytotoxic agents. The Alloc group exhibits stability under treatment with piperidine and TFA, yet can be efficiently removed under mild conditions through palladium-catalyzed allyl transfer, making it a versatile component for precise drug delivery applications.

γ-Glu-Val-Gly is a cleavable linker widely utilized in antibody-drug conjugates (ADCs). This compound features a peptide bond susceptible to enzymatic cleavage, enabling the selective release of cytotoxic agents within target cells. Its application in ADC development supports targeted cancer therapy by enhancing the delivery and efficacy of therapeutic agents while minimizing systemic toxicity.

Fmoc-D-Lys(N3)-OH is a chemical reagent featuring an azide moiety, which serves as a key element in click chemistry applications. This compound can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules and can also undergo strain-promoted azide-alkyne cycloaddition (SPAAC) with dibenzocyclooctyne (DBCO) or bicyclononyne (BCN) functionalities. Fmoc-D-Lys(N3)-OH is valuable for various biochemical research applications, particularly in the development of bioconjugates and chemical probes.

Azido-PEG8-acid is a non-cleavable linker composed of eight polyethylene glycol (PEG) units, specifically designed for use in antibody-drug conjugates (ADCs) and PROTACs. It serves as a versatile click chemistry reagent due to its azide functionality, facilitating copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it supports strain-promoted alkyne-azide cycloaddition (SPAAC) reactions when interacting with DBCO or BCN groups. This compound is essential for researchers focusing on the development of targeted therapeutic agents and protein degradation strategies.

DBCO-NHCO-S-S-NHS ester is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound contains a DBCO group, facilitating strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Its application is crucial in the construction of targeted therapies, enabling the selective delivery of cytotoxic agents to specific cells.

Boc-Val-Ala-PAB-PNP is a cleavable linker designed for the development of antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic agents in targeted cancer therapies, making it invaluable for the construction of ADCs. Its specific design allows for stable attachment to antibodies while enabling controlled drug release in the tumor microenvironment, thus enhancing therapeutic efficacy.

1-Boc-azetidine-3-yl-methanol serves as a non-cleavable linker in the synthesis of antibody-drug conjugates (ADCs). This compound is also utilized as an alkyl chain-based linker in the development of proteolysis-targeting chimeras (PROTACs). Its unique chemical structure facilitates the effective conjugation of therapeutic agents, enhancing delivery and efficacy in targeted cancer therapies.

Boc-Hyp-OMe is a non-cleavable linker that serves as an essential component in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. Its alkyl chain structure facilitates the conjugation of therapeutic agents, enabling targeted delivery and improved therapeutic efficacy. Boc-Hyp-OMe is valuable for researchers focusing on drug development and molecular biology, particularly in studies involving targeted protein degradation and the design of innovative therapeutic modalities.

Fmoc-NH-ethyl-SS-propionic acid is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic drugs in targeted cancer therapy, enhancing therapeutic efficacy while minimizing off-target effects. Its application in ADC development supports advancements in personalized medicine and targeted treatment strategies for malignancies.

Azido-PEG5-acid is a polyethylene glycol (PEG)-based linker designed for PROTAC (Proteolysis Targeting Chimeras) synthesis. This non-cleavable linker facilitates the development of conjugates and antibody-drug conjugates (ADCs) through its azide functionality. Azido-PEG5-acid participates in click chemistry, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing substrates, and can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups. Its versatility makes it valuable for various applications in chemical biology and drug discovery.

Fmoc-Lys(Pal-Glu-OtBu)-OH is a non-cleavable linker employed in the synthesis of antibody-drug conjugates (ADCs). This compound features a lysine residue with a palmitic acid-modified glutamic acid and tert-butyl ester, providing enhanced stability and solubility. Its structure also allows for use as an alkyl chain-based linker in the development of proteolysis-targeting chimeras (PROTACs), facilitating targeted protein degradation in various research applications. This versatility makes it a valuable reagent for advanced bioconjugation techniques and drug delivery systems.

Propargyl-PEG5-amine is a non-cleavable linker utilized in antibody-drug conjugates (ADCs) and PROTAC synthesis. This PEG-based compound features an alkyne functional group, enabling efficient click chemistry through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. Propargyl-PEG5-amine is valuable for researchers developing innovative therapeutic strategies involving targeted protein degradation and selective delivery of cytotoxic agents.

Maleimido-tri(ethylene glycol)-propionic acid is a cleavable linker designed for use in antibody-drug conjugates (ADCs). It facilitates the synthesis of neolymphostin-based ADC precursors, enabling site-specific conjugation to cysteine mutant trastuzumab-A114C. Additionally, this compound serves as a PEG-based linker in the development of PROTACs, contributing to research in targeted protein degradation and therapeutic applications.

DBCO-C6-acid is a non-cleavable ADC linker that facilitates the formation of antibody-drug conjugates (ADCs). Its unique DBCO moiety allows for efficient strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing compounds. This reagent is particularly useful in the synthesis of carmaphycin analogues, enabling targeted delivery of therapeutic agents for enhanced efficacy in research applications related to targeted cancer therapies.

Bis-PEG7-NHS ester is a PEG-based linker designed for use in the synthesis of PROTACs and antibody-drug conjugates (ADCs). Its NHS ester functionality facilitates conjugation, enabling the attachment of therapeutic agents to targeting antibodies or protein degradation components. This versatility supports research applications in targeted therapy and protein modulation, making it a valuable tool in drug development and protein engineering studies.

3,3'-(Propane-2,2-diylbis(sulfanediyl))dipropionic acid serves as an ROS-sensitive cleavable linker, facilitating the synthesis of antibody-drug conjugates (ADCs). Its unique mechanism allows for controlled release in response to reactive oxygen species, making it particularly valuable in the development of targeted tumor drug delivery systems. This compound is essential for researchers seeking to enhance therapeutic efficacy through precise chemical conjugation strategies.

Propargyl-PEG3-NHS ester is a PEG-based linker designed for use in the development of PROTACs and antibody-drug conjugates (ADCs). This cleavable linker features an alkyne group, allowing for efficient synthesis through click chemistry. It specifically enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules, making it a valuable tool for researchers in the fields of drug conjugation and targeted protein degradation.

Amino-PEG6-alcohol is a non-cleavable linker composed of a six-unit polyethylene glycol (PEG) chain, primarily utilized in the formulation of antibody-drug conjugates (ADCs) and PROTACs (proteolysis-targeting chimeras). This versatile PEG-based linker enhances the solubility and stability of the final conjugate, facilitating targeted therapeutic applications. It is essential for researchers working on the development of innovative therapeutic strategies in cancer and other diseases through the use of ADCs and PROTACs.

TCO-PEG12-NHS ester is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras) and antibody-drug conjugates (ADCs). This cleavable linker facilitates the conjugation of therapeutics, enabling targeted degradation of specific proteins via the ubiquitin-proteasome pathway. Its unique properties make it suitable for advancing research in targeted therapies and optimizing drug delivery systems.

Boc-NH-PEG4-CH2COOH is a cleavable linker designed for use in antibody-drug conjugates (ADCs) and PEG-based PROTACs (Proteolysis Targeting Chimeras). This compound facilitates the construction of PROTACs by providing a flexible and stable linkage that enhances biological activity. Its applications include targeted protein degradation research and the development of innovative therapeutic strategies in oncology and other diseases.

m-PEG3-CH2CH2COOH is a non-cleavable linker designed for use in antibody-drug conjugates (ADCs). This multifunctional PEG-based moiety also serves as a PROTAC linker, facilitating the synthesis of proteolysis-targeting chimeras. Its unique structure enhances stability and solubility, contributing to effective delivery and targeted therapy applications in chemical biology and drug development.

Propargyl-PEG3-acid is a versatile non-cleavable linker designed for antibody-drug conjugates (ADCs) and PEG-based PROTAC applications. Its structure includes a three-unit polyethylene glycol (PEG) moiety and an alkyne group, enabling efficient copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules. This reagent is key in the synthesis of advanced bioconjugates, such as 6-OHDA-PEG3-yne, combining the bioactivity of 6-OHDA with the stability of the linker for targeted therapeutic applications.

Azido-PEG6-alcohol is a PEG-based linker designed for use in PROTAC synthesis, enhancing the development of targeted protein degradation strategies. This compound functions as a non-cleavable linker for antibody-drug conjugates, facilitating effective delivery of therapeutics. As a versatile click chemistry reagent, Azido-PEG6-alcohol features an azide group capable of participating in copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules. Its applications extend to the fields of drug delivery and bioconjugation in chemical biology research.

Propargyl-PEG4-Br is a PEG-based linker designed for use in antibody-drug conjugates (ADCs) and PROTACs, facilitating effective targeted delivery of therapeutic agents. This non-cleavable linker integrates an alkyne group, enabling its application in click chemistry through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. Propargyl-PEG4-Br is essential for the synthesis of advanced bioconjugates to enhance therapeutic efficacy and specificity in research applications.

Propargyl-C2-NHS ester is a non-cleavable linker designed for antibody-drug conjugation (ADC) applications. This compound features an alkyne functional group enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules. Its stability and efficiency make it an essential tool for researchers developing targeted therapies through ADC technology.

m-PEG12-amine is a polyethylene glycol (PEG)-based linker designed for use in antibody-drug conjugates (ADCs) and PROTAC synthesis. This non-cleavable 12-unit PEG linker enhances the stability and solubility of ADCs, facilitating targeted delivery of therapeutic agents. Its application in PROTAC development aids in the effective degradation of specific target proteins, thus advancing research in targeted protein modulation and therapeutic interventions.

Amino-Tri-(carboxyethoxymethyl)-methane is a versatile cleavable PEG linker designed for the synthesis of antibody-drug conjugates (ADCs). Its unique structure facilitates controlled release of cytotoxic agents, enhancing the therapeutic efficacy of ADCs. Additionally, this compound serves as a PEG-based linker for the development of PROTACs, providing optimized performance in targeted protein degradation research applications.

N3-Ph-NHS ester is a non-cleavable linker for antibody-drug conjugates (ADCs), designed to facilitate the synthesis of these complex bioconjugates. As a click chemistry reagent, it features an azide functional group, enabling efficient copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it is capable of participating in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN moieties, making it a versatile tool for chemical biologists engaged in ADC development.

Fmoc-NH-PEG1-CH2COOH is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This PEG-based compound facilitates the construction of ADCs by linking antibodies to cytotoxic agents while ensuring controlled release. Additionally, it serves as a versatile linker in the development of PROTACs, enabling effective targeted protein degradation for various research applications in drug discovery and development.

Azido-methyltetrazine di-arm linker is a novel linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This multivalent linker facilitates the conjugation of therapeutic agents to antibodies, enhancing the efficacy and targeting capabilities of ADCs. It is an essential reagent for researchers exploring the development of targeted cancer therapies and improving the selectivity of drug delivery systems.

DBCO-PEG4-amine is a PEG-based linker designed for use in the synthesis of PROTACs and antibody-drug conjugates (ADCs). This versatile cleavable linker allows for efficient conjugation through its DBCO group, enabling strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with azide-containing molecules. Its applications extend to the creation of homobifunctional cross-linkers, such as FPM-PEG4-DBCO, facilitating advanced drug delivery and targeted degradation strategies in chemical biology research.

Azido-PEG9-amine is a non-cleavable linker comprising a 9-unit polyethylene glycol (PEG) chain, primarily utilized in the synthesis of antibody-drug conjugates (ADCs). This versatile reagent features an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. Additionally, it can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) with compounds containing DBCO or BCN groups, making it suitable for applications in PROTAC synthesis and click chemistry.

1-Cbz-azetidine-3-carboxylic acid serves as a non-cleavable linker for antibody-drug conjugates (ADCs), enabling the targeted delivery of therapeutics to specific cells. This compound is also employed as an alkyl chain-based linker in the synthesis of Proteolysis Targeting Chimeras (PROTACs), facilitating protein degradation pathways in research applications. Its versatile functionality makes it a valuable tool in bioconjugation and targeted therapy research.

m-PEG6-NHS ester is a non-cleavable linker designed for applications in PROTAC synthesis. This 6-unit polyethylene glycol (PEG) linker plays a crucial role in the construction of antibody-drug conjugates (ADCs), enabling effective cellular delivery of therapeutic agents. Its unique structure facilitates the conjugation of various biomolecules, making it a valuable tool for researchers in the fields of targeted drug delivery and protein degradation studies.

(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate is a non-cleavable linker for antibody-drug conjugates (ADCs). This compound facilitates the synthesis of ADCs by providing a stable connection between the antibody and the cytotoxic agent. Additionally, it serves as a suitable linker in the development of PROTACs, enhancing the design of targeted protein degradation strategies in biochemical research.

BCN-exo-PEG7-maleimide is an ADC linker featuring a polyethylene glycol (PEG) spacer of seven units, facilitating improved solubility and stability. This compound incorporates the bidentate macrocyclic ligand BCN, enabling efficient synthesis of macrocyclic complexes. In click chemistry applications, BCN selectively reacts with azide-containing molecules to yield stable triazoles without the need for catalysts. Additionally, the maleimide functional group undergoes hydrolytic degradation, making it suitable for drug delivery research.

Fmoc-Gly-NH-CH2-O-Cyclopropane-CH2COOH is an ADC linker intermediate that facilitates the conjugation of cytotoxic agents to antibodies. This compound features a benzyl 2-cyclopropyl-2-hydroxyacetate moiety and is designed for use in the synthesis of antibody-drug conjugates (ADCs), enhancing the therapeutic potential of targeted cancer treatments. It is suitable for research applications in the development of ADCs, including those involving agents such as Exatecan.

H-(Gly)3-Lys(N3)-OH hydrochloride is a versatile click chemistry reagent featuring an azide group that enables efficient copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. This compound also supports ring strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN-modified substrates. Its high yield, specificity, and simplicity make it suitable for various research applications, including the labeling and functionalization of nucleic acids, lipids, and proteins, thereby facilitating advanced studies in chemical biology and bioconjugation.

Cy5.5 DBCO is a cycloalkyne-based click chemistry reagent featuring a cyanine 5.5 fluorophore. The presence of the DBCO moiety facilitates copper-free, biocompatible click reactions characterized by rapid kinetics and enhanced stability. This reagent is widely utilized in bioconjugation applications, enabling efficient labeling of biomolecules for imaging and detection in various biological studies.

Bis-PEG1-NHS ester is a non-cleavable linker designed for antibody-drug conjugation (ADC) applications. This 1-unit polyethylene glycol (PEG) linker enhances the solubility and stability of conjugates while maintaining effective targeting. It is utilized in the development of ADCs to improve therapeutic efficacy and minimize off-target effects, making it a valuable tool in bioconjugation research.

Val-Cit is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). It facilitates the selective release of cytotoxic drugs upon internalization, enhancing the therapeutic efficacy of ADCs. This compound is pivotal in cancer research, enabling the targeted delivery of therapeutics to malignant cells while minimizing systemic toxicity.

Tetrazine-SS-Biotin is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). Featuring a Tetrazine moiety, it facilitates the inverse electron demand Diels-Alder reaction with trans-cyclooctene (TCO) derivatives. This unique reactivity enables precise targeting and controlled release of therapeutic agents, making it valuable in cancer research and the development of targeted therapies.

Propargyl-PEG5-NHS ester is a cleavable linker primarily used in the synthesis of antibody-drug conjugates (ADCs) and PROTAC molecules. This PEG/alkyl/ether-based compound features an alkyne functionality, facilitating click chemistry through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing partners. Its versatility makes it suitable for various applications in targeted protein degradation and the development of ADCs, supporting advanced research in drug delivery and molecular biology.

Azido-PEG5-CH2CO2H is a cleavable 5-unit PEG linker designed for use in the synthesis of antibody-drug conjugates (ADCs) and efficiently functions as a PEG-based PROTAC linker. This compound features an azide group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN groups. Its versatile reactivity positions Azido-PEG5-CH2CO2H as a valuable tool in chemical biology, particularly in targeted therapeutics and drug delivery systems.

(2-pyridyldithio)-PEG1-hydrazine is a cleavable linker designed for use in antibody-drug conjugate (ADC) synthesis. This reagent facilitates the attachment of therapeutic agents to antibodies, ensuring selective delivery to target cells. Its PEGylated structure enhances solubility and stability, making it suitable for various bioconjugation applications in drug development and cancer research.

Mc-Val-Ala-PAB is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates targeted drug delivery by enabling the release of cytotoxic agents upon internalization and cleavage within target cells. Its application in ADC development enhances the therapeutic potential and specificity of anticancer therapies.

Bromoacetamido-PEG4-acid is a PEG-based linker designed for PROTAC (proteolysis-targeting chimera) synthesis. This compound exhibits crucial properties for the development of targeted protein degradation strategies. In addition, it serves as a cleavable linker in antibody-drug conjugate (ADC) technology, facilitating the conjugation of therapeutic agents to antibodies for improved specificity and efficacy in cancer treatment. Its versatile applications make it essential for advancements in targeted therapies and drug delivery systems.

MC-Ala-Ala-PAB is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This reagent facilitates the conjugation of therapeutic agents to antibodies, enabling targeted delivery in cancer research. Its ability to cleave in specific environments enhances the release of the drug in targeted tissues, which is critical for maximizing therapeutic efficacy and minimizing off-target effects.